鼻内激素用于儿童分泌性中耳炎:质量改进的持续机会
该研究基于2005至2012年美国门诊医疗调查行政数据库的横断面分析,评估儿童分泌性中耳炎(OME)诊断时鼻内激素的使用模式。结果显示,OME诊断访视中鼻内激素使用率为10.0%,无OME诊断访视为3.5%(单变量OR 3.07,95%CI 1.85-5.08,P<.001);多变量分析后OME仍与鼻内激素使用增加相关(OR 3.58,95%CI 1.60-8.01,P=.002)。该实践模式在门诊诊所更常见(风险差6.6%,P<.001),在医院诊所或急诊科较少见。尽管随机对照试验显示鼻内激素对孤立性OME缺乏疗效,其仍在被用于治疗儿童OME。
要点
- OME诊断访视中鼻内激素使用率为10.0%,无OME诊断访视为3.5%(单变量OR 3.07)。
- 调整混杂因素后,OME仍与鼻内激素使用增加相关(OR 3.58,95%CI 1.60-8.01)。
- 该实践模式在门诊诊所更常见(风险差6.6%,P<.001),医院诊所或急诊科较少见。
核心结论
- 尽管随机对照试验显示鼻内激素对孤立性OME缺乏疗效,其仍继续被用于治疗美国儿童OME。
- 存在与预防使用无效治疗相关的质量改进机会。
研究设计与样本
- 横断面分析行政数据库。
- 数据来源为2005至2012年全国门诊医疗调查和医院门诊医疗调查,代表1,943,177,903次访视。
- 进行单变量、多变量和分层分析,主要结局为鼻内激素使用,主要预测因子为OME诊断。
主要发现
- OME诊断访视中鼻内激素使用率为10.0%,无OME诊断访视为3.5%(单变量OR 3.07,95%CI 1.85-5.08,P<.001)。
- 调整年龄、性别、种族/民族和其他混杂状况后,OME仍与鼻内激素使用增加相关(OR 3.58,95%CI 1.60-8.01,P=.002)。
- 该实践模式在门诊诊所更常见(风险差6.6%,P<.001),在医院诊所或急诊科较少见。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objectives Our objectives were (1) to assess patterns of intranasal steroid administration when otitis media with effusion (OME) has been diagnosed in children, (2) to investigate whether usage varies according to visit setting, and (3) to determine if practice gaps are such that quality improvement could be tracked. Study Design Cross-sectional analysis of an administrative database. Subjects and Methods National Ambulatory and Hospital Ambulatory Medical Care Surveys, 2005 to 2012; univariate, multivariate, and stratified analyses of intranasal steroid usage were performed. The primary outcome was intranasal steroid administration, and the primary predictor was a diagnosis of OME. The impact of location of service was also analyzed. Results Data representing 1,943,177,903 visits demonstrated that intranasal steroids were administered in 10.0% of visits in which OME was diagnosed, in comparison to 3.5% of visits in which OME was not diagnosed (univariate odds ratio, 3.07; 95% confidence interval [CI], 1.85-5.08; P < .001). After adjusting for age, sex, race/ethnicity, and other confounding conditions, multivariate analysis demonstrated that OME remained associated with an increase in intranasal steroid usage (odds ratio, 3.58; 95% CI, 1.60-8.01; P = .002). This practice pattern was more prevalent in the ambulatory office setting (risk difference 6.6%, P < .001) and less seen in a hospital-based office or emergency department. Conclusion Despite randomized controlled trials showing a lack of efficacy for isolated OME, nasal steroids continue to be used in treating children with OME in the United States. Related quality improvement opportunities to prevent usage of an ineffective treatment exist.
引用
- Wang DE, Lam DJ, Bellmunt AM, et al. Intranasal Steroid Use for Otitis Media with Effusion: Ongoing Opportunities for Quality Improvement. Otolaryngol Head Neck Surg. 2017. PMID: 28535109. doi:10.1177/0194599817703046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。